跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOMETASONE NTC NASAL SPRAY SUSPENSION 50 MCG/ACTUATION - HSA Drug Approval Details
Approvals
/
HSA
/
MOMETASONE NTC NASAL SPRAY SUSPENSION 50 MCG/ACTUATION
Approved
THERAPEUTIC
MOMETASONE NTC NASAL SPRAY SUSPENSION 50 MCG/ACTUATION
MIPHARM S.P.A (ITALY)
🇸🇬 Health Sciences Authority
Approval Date
Feb 26, 2018
Approval ID
1759f2cd12358220
Company
MIPHARM S.P.A (ITALY)
Type
Therapeutic
Approval Details
Approval Id
1759f2cd12358220
Drug Name
MOMETASONE NTC NASAL SPRAY SUSPENSION 50 MCG/ACTUATION
Product Name
MOMETASONE NTC NASAL SPRAY SUSPENSION 50 MCG/ACTUATION
Approval Number
SIN15434P
Approval Date
2018-02-26
Registrant
NOVEM HEALTHCARE PTE LTD
Licence Holder
NOVEM HEALTHCARE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
SPRAY, SUSPENSION
Route Of Administration
NASAL
Atc Code
R01AD09
Atc Item Name
mometasone
Pharma Manufacturer Name
NOVEM HEALTHCARE PTE LTD
Active Ingredients
Mometasone furoate monohydrate 51.7mcg equivalent to Mometasone furoate
50mcg/actuation
MOMETASONE FUROATE MONOHYDRATE 51.7 MCG EQUIVALENT TO MOMETASONE FUROATE
50 MCG/ACTUATION
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 26, 2018
Approval ID
1759f2cd12358220
Type
Therapeutic
Back to HSA Approvals
